Dementia Research centre news

We are pleased to announce the appointment of Professor Jonathan Schott as a new Group Leader, to support UK DRI at UCL in delivering its vision of healthy brain ageing for all.

Differences in the distribution of certain proteins and markers in the brain may explain why some people first experience vision changes instead of memory loss in Alzheimer’s disease, finds a new study by UCL Queen Square Institute of Neurology researchers.

UCL Queen Square Institute of Neurology held its first inaugural lecture evening of 2025, on 4th March 2025.

People who exercise throughout their lives have a better chance of avoiding dementia – even if they show signs of diseases like Alzheimer’s, finds a new study led by UCL Queen Square Institute of Neurology researchers.

UCLH has recruited the first participant to an international trial in frontotemporal dementia (FTD), one of the most common causes of early-onset dementia.

UCLH has recruited the first participant to a global study of a new drug in early development, called NI0752, which is thought to reduce the production of a protein in the brain called tau.

Dr Chris Hardy (Dementia Research Centre, UCL Queen Square Institute of Neurology) has been announced as Alzheimer’s Society’s second Carol Jennings Fellow.

A loss of brain volume associated with new immunotherapies for Alzheimer’s disease may be caused by the removal of amyloid plaques, rather than the loss of neurons or brain tissue, finds a study led by UCL researchers.

One of the UK’s largest philanthropic foundations has extended its support for the Neurogenetic Therapies Programme at UCL until 2029, enabling researchers to further advance treatments for neurodegenerative and dementia-causing diseases. 

The Medicines and Healthcare Products Regulatory Agency (MHRA) has licensed the immunotherapy drug, Lecanemab, for use in the early stages of Alzheimer’s disease in the UK, following decades of work supported by UCL research.

Drugs with the potential to change the course of Alzheimer’s disease are expected to be approved by mid-year in the UK. However, healthcare services may need to change to ensure that all patients have equitable access to these new modifying anti-amyloid therapies.

Principal Research Fellow at the UCL Queen Square Institute of Neurology, Dr Aida Suarez Gonzalez, has been appointed as president of the World Federation of Neurology’s Aphasia, Dementia and other Cognitive Disorders (ADCD) Speciality Group.

A new BBC documentary, The Jennings vs Alzheimer’s, explores the discoveries made by researchers at UCL and UCLH that have given hope for Alzheimer’s disease over the past four decades, and the very special family that helped make it happen.

Thousands of people in the UK are to take part in countrywide trials to identify accurate and quick blood tests that can diagnose dementia, led by research teams at Queen Square Institute of Neurology

Five cases of Alzheimer’s disease are believed to have arisen as a result of medical treatments decades earlier, reports a team of UCL and UCLH researchers.